[2025] Registered attendees may download approved presentations for a limited time. See below.

Thank you for attending. Please click on the TITLE below that corresponds with the presentation you are looking for.

 

Program: NEW YORK LUNG CANCER LEARNING CENTER

[March 20th-22nd, 2025] Click on any of the section titles below to access all of the presentations.

FRIDAY PRESENTATIONS

SCLC Status 2025

N2 Patients

Lung Cancer Screening - Never Smokers

Liquid Biopsy for Early Cancer Detection

Perioperative Immunotherapy: The Rollercoaster Keeps Rolling

Escalation and de-escalation IO strategies

Next Steps: Early Stage

Perioperative TKIs Neoadjuvant and Adjuvant Opportunities and Challenges

Assumptions for oncogene-addiction strategy expansion

What to Do (for common and rare mutations)

Does the marginally resectable become resectable?

Molecular alterations beyond EGFR in stage III NSCLC

Therapeutic updates in EGFR including resistance

Therapeutic updates in ALK-rearranged NSCLC including resistance.

Liquid Biopsy: Diagnosis and Monitoring

Immunotherapy for advanced NSCLC: State of the Art

New modalities for frontline and resistance strategies

Immunotherapy for advance non-small cell lung cancer

New strategies including T cell engagers and ADCs

Panel Discussion: Action Items and Next Steps for Small Cell Lung Cancer (SCLC)

New Steps in Screening & Cancer Early Interventions

SATURDAY PRESENTATIONS

IASLC Perspectives

ETOP Perspectives

Pragmatic & Decentralized Trials Regulatory Perspective

Predicting and Overcoming Payer Barriers—and Other Financial Barriers

How disparities are affecting cancer care?

How are disparities affecting cancer care in EU?

How are disparities affecting cancer care in Asia

Multi Regional Clinical Trials Regulatory Perspective

Unmet Needs and Perspectives